GlassScriptPhysician profile
Leonard Gerald Gehl
NPI 1245299718
$1,514.22
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,514.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $297.30 | 2019 | |
| Boston Scientific Corporation | $220.37 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $179.66 | 2019 | |
| Pfizer INC. | $116.09 | 2019 | |
| Astellas Pharma US INC | $98.06 | 2019 | |
| Biotronik INC. | $91.73 | 2019 | |
| United Therapeutics Corporation | $72.77 | 2019 | |
| Sanofi-Aventis U.S. LLC | $70.33 | 2019 | |
| Akcea Therapeutics, INC. | $66.43 | 2019 | |
| Janssen Pharmaceuticals, INC | $62.86 | 2019 | |
| Amgen INC. | $62.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $33.38 | 2019 | |
| Corindus INC. | $32.26 | 2019 | |
| Gilead Sciences, INC. | $31.16 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.61 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $15.26 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.16 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.16 | 2019 | |
| Lundbeck LLC | $13.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Gehl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.